MENU

ATYR Stock aTyr Pharma (ATYR, $3.38) Stochastic Oscillator left the oversold zone on December 23, 2024

A.I.dvisor
at Tickeron.com
Loading...
ATYR - aTyr Pharma Inc
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $3.38
Daily change: +$0.03 (+0.9%)
Daily volume: 754.4K
Capitalization: $283.7M
Industry: Biotechnology
This is a signal that ATYR's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 67 similar cases where ATYR's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

Aroon Indicator for ATYR shows an upward move is likely

ATYR's Aroon Indicator triggered a bullish signal on November 22, 2024. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 135 similar instances where the Aroon Indicator showed a similar pattern. In of the 135 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where ATYR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 24, 2024. You may want to consider a long position or call options on ATYR as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ATYR just turned positive on December 24, 2024. Looking at past instances where ATYR's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

ATYR moved above its 50-day moving average on December 17, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATYR advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for ATYR crossed bearishly below the 50-day moving average on December 24, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATYR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATYR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.396) is normal, around the industry mean (14.516). P/E Ratio (0.000) is within average values for comparable stocks, (87.040). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.755). ATYR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1000.000) is also within normal values, averaging (259.546).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATYR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details